Arisan Therapeutics
About:
Arisan Therapeutics is a life science company that develops novel solutions for the treatment of neglected and emerging infectious diseases.
Website: http://www.arisanthera.com/
Top Investors: National Institute of Allergy and Infectious Diseases
Description:
Arisan Therapeutics develops therapeutics for neglected and emerging viral diseases. They offer infectious diseases that have the potential for significant impact on public health and have been classified as priority biodefense-related pathogens.
Total Funding Amount:
$1M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2010-01-01
Founders:
Greg Henkel, Ken McCormack
Number of Employees:
1-10
Last Funding Date:
2019-06-27
IPO Status:
Private
Industries:
© 2025 bioDAO.ai